(SLNO) – Litigation
-
Soleno Therapeutics (SLNO) Announces New U.S. Patent for DCCR Covering Treatment of Hyperphagia in PWS
-
Soleno Therapeutics (SLNO) Reports New U.S. Patent for DCCR in Treatment of Prader-Willi Syndrome
Back to SLNO Stock Lookup